← BackAxil Brands, Inc. · Perfumes, Cosmetics & Other Toilet PreparationsAXIL
Low riskNext report: Around Jan 7, 2027 (est.)
The short versionA profitable company with shrinking sales. Institutions are adding.
Going well
- Profitable
- Sales up 18% last year
- Little debt
Watch out for
- Sales down 11% in the latest quarter vs a year ago
- Share count growing 5.3% a year
Money moves
- No insider buying or selling in the last 30 days
- Institutions added 14% to their holdings in the quarter ending June 2026 (7 bought, 5 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$5.56+0.7% that day
- Company value
- $38M
- Share price times all shares
- Price vs profit (P/E)
- 16.4x
- You pay about $16 for each $1 of yearly profit
- Price vs sales
- 1.3x
- Company value is 1.3 times a year of sales
- Cash vs value
- 21%
- Cash as a share of company value
- Debt vs value
- 0%
- Debt as a share of company value
From AXIL's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Aug '26$6.1M-11% vs a year earlier
Nov '23Tap a barAug '26
Last 12 months: $30.1M, up 10% from the 12 months before. Over 5 years, sales grew about 80% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- PassReturn on equity 15%+Earns a lot on the money owners have in the business.27.1%
- PassDebt under half of equityNot relying on borrowed money.0.01x equity
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.8.8%
- MissProfitable every yearSteady profits, not one good year.4 of 10 years
- MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$89K
- MissShare count not growingNot diluting owners. Falling means buybacks.+16.8% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.69.3%
- Revenue
- $30.8M
- +17.5% vs prior year
- 5-year growth
- +80.0%/yr
- revenue, per year
- Total debt
- $138K
- 0.01x equity
- Current ratio
- 2.75x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Aug 31, 2026- Revenue
- $6.1M
- -11.2% YoY
- EPS
- $0.05
- vs $0.04
- Op. margin
- 7.2%
- +1.2 pts
- Gross margin
- 82.6%
- +15.0 pts
- Free cash flow
- $3.7M
- Share count
- +0.1%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
86/ 100
- This week
- 3
- Normal week
- 0.5
- vs normal
- 6.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
▲Accumulating+13.6%Institutions added 13.6% to their holdings. 7 bought, 5 sold.
Shares held by institutions1.1M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
+5.3%Cash runwayAt last year's cash burn
9875 monthsDebt to equityLatest balance sheet: debt compared with what owners have
0.0x · $138K debtShares outstandingLatest reported
7MWhy low risk- Share count growing 5.3% a year
Next reportAround Jan 7, 2027 (est.)Estimated from the same quarter last year
- Results filedOct 6
- Results filedAug 18
- Results filedApr 8
- Results filedJan 8
- Results filedOct 7, 2025
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.